Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg
Clinical trial NCT00647972 · TERMINATED
Trial details
- NCT number
- NCT00647972
- Sponsor
- Mylan Pharmaceuticals Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-05-01
- Primary completion
- 2003-05-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.